GFAP and Alzheimer disease: In fact, GFAP is an indicator of neuroinflammation in the CNS25 and it is also involved in the progression of neurodegeneration in ischemia, AD, MS, Amyotrophic Lateral Sclerosis (ALS) and PD26–28.